SEO URLwww.firestrike.ai/deals/dynavax-technologies-sanofi-acquisition-2026-4
acquisitionAnnounced · Jan 20, 2026BiotechnologySource · CredibleArticle · Factual
Sanofi acquires Dynavax Technologies
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$2.2B
Target
Dynavax Technologies
NASDAQ: DVAX · Emeryville, California
Acquirer
Sanofi
Full Acquisition
Status
Pending
Sanofi agreed to acquire Dynavax Technologies. Reported deal value: $2.2B. Status: Pending. Sector: Biotechnology. Target headquarters context: Emeryville, California, United States.
This page summarizes publicly available information about the transaction as of 2026-01-20. Figures and status may change as filings and press coverage update.
Sanofi has agreed to acquire Dynavax Technologies , a vaccine development company whose pipeline includes a shingles vaccine candidate
Deal timeline
Announced
Jan 20, 2026 · managedhealthcareexecutive.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology with a reported deal value of $2.2B. Figures and status may change as sources update.
Sources: managedhealthcareexecutive.com · Primary article · FireStrike proprietary index